LAVA Therapeutics N.V.
LVTX
$1.24
-$0.01-0.80%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/16/2025
-
GuruFocus
4/16/2025
-
GuruFocus
4/16/2025
-
GuruFocus
4/16/2025
-
The Fly
4/16/2025
-
Globe Newswire
4/6/2025
-
Simply Wall St
3/29/2025
-
Ticker Report
3/28/2025
-
TipRanks Financial Blog
3/28/2025
-
GuruFocus
3/28/2025
-
The Fly
3/28/2025
-
The Fly
3/28/2025
-
The Fly
3/28/2025
-
Globe Newswire
2/27/2025
-
The Fly
2/26/2025
-
TipRanks Financial Blog
2/25/2025
-
BizJournals.com - Nat'l Business News
2/25/2025
-
The Fly
2/25/2025
-
The Fly
2/25/2025
-
Globe Newswire
1/10/2025
-
The Fly
1/10/2025
-
Globe Newswire
1/2/2025
-
TipRanks Financial Blog
12/20/2024
-
The Fly
12/15/2024
-
Ticker Report
12/14/2024
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, March 28, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 19 and 23 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
31 85 016 3100
Address
Yalelaan 62
Utrecht, 3584 CM
Utrecht, 3584 CM
Country
Year Founded
Business Description
Sector
LAVA Therapeutics N.V. operates as a clinical-stage immuno-oncology company that focuses on developing cancer treatments. The company through its Gammabody platform, develops a portfolio of novel...
more